NRZ
Asset Logo

Neurizer Ltd

πŸ‡¦πŸ‡Ί ASX

πŸ§ͺ CHEMICALS

Compare
Add to watchlist
πŸ‘‘ Overview

πŸ“ˆ Performance

πŸ’΅ Cost

πŸ€“ Advanced

πŸ‘¨β€πŸ‘©β€πŸ‘§β€πŸ‘¦ Community

πŸ“ˆ

-19.61%
Annual Growth

5 years average annual growth

πŸ’΅

$ 500
Minimum Order

Due to regulatory requirements

🌏

16
Pearlers Invested

Since January 2020

πŸ‘‘ Overview

Key information
πŸ”Ž Fund Overview

NeuRizer Ltd. engages in the development of NeuRizer Urea Project (NRUP). The company is headquartered in Adelaide, South Australia. The company went IPO on 2005-03-17. The firm is focused on the development of NeuRizer Urea Project (NRUP). The NRUP project is located in South Australia, approximately 550 kilometers north of Adelaide. The NRUP is a fully integrated urea production facility in Australia, with all inputs (gas, power, and carbon di oxide) for low carbon urea production on-site. The NRUP project delivers nitrogen-based fertilizer supply to local and export agriculture markets. The company uses in-situ gasification to produce syngas from the deep Leigh Creek coal seams, and use this syngas to produce urea, a commonly used fertilizer. The firm produces approximately one million tons per annum (Mtpa) of urea fertilizer with the potential to increase to two Mtpa.

πŸ“ˆ Performance

Price History

-84.00%

1M

1Y

10Y

Graph

Table

Unsure how much or often to invest?
πŸ—“οΈ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out β†’
πŸ’΅ Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out β†’
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out β†’

πŸ’΅ Costs

πŸ’΅

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

πŸ’Ό

N/A
Management Fee

Included in unit price, not charged by Pearler

πŸ’Έ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πŸ’Έ Net fee calculator

πŸ€“ Advanced information

Technical Info

πŸ’° Price*

$0.00

*Price may be up to 24 hours old

πŸ‘©β€πŸ‘©β€πŸ‘¦ Community Insights

How our community is investing

🌏 Pearlers invested in NRZ

16

πŸ“Š Total Capital Earnings

$23K

πŸ”ƒ Average investment frequency

33 weeks

πŸ’΅ Average investment amount

$1,335

⏰ Last time a customer invested in NRZ

119 days
NRZ investor breakdown
πŸ’΅ Income of investors

More than 200k

150k - 200k

100k - 150k

13%

50k - 100k

50%

Less than 50k

38%
πŸ‘Ά Age of investors

18 - 25

26 - 34

50%

35 - 90

44%
πŸ™‹ Legal gender of investors

Female

38%

Male

63%

Pearlers who invest in NRZ also invest in...

Neurizer Ltd

NRZR

NeuRizer Ltd. engages in the development of NeuRizer Urea Project (NRUP). The company is headquartered in Adelaide, South Australia. The company went IPO on 2005-03-17. The firm is the carbon neutral producer of urea fertilizer. The firm is focused on the development of NeuRizer Urea Project (NRUP). The NRUP project is located in South Australia, approximately 550 kilometers north of Adelaide. The NRUP is a fully integrated urea production facility in Australia, with all inputs (gas, power, and carbon di oxide) for low carbon urea production on-site. The NRUP project delivers nitrogen-based fertilizer supply to local and export agriculture markets. The company uses in-situ gasification to produce syngas from the deep Leigh Creek coal seams, and use this syngas to produce urea, a commonly used fertiliser. The firm produces approximately one million tons per annum (Mtpa) of urea fertilizer with the potential to increase to two Mtpa.

πŸ“Š Share price

$0.00 AUD

NULL STOCK

Find Out More

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.85%

πŸ“Š Share price

$100.90 AUD

⛳️ DIVERSIFIED

πŸ‡¦πŸ‡Ί AUSTRALIA

🧱 MATERIALS

πŸ’Έ FINANCIALS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

12.86%

πŸ“Š Share price

$129.54 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

πŸ€– TECHNOLOGY

πŸ“ˆ HIGH PRICE GROWTH

Weebit Nano Ltd. engages in developing and commercializing silicon oxide and Resistive Random-Access Memory technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-12-21. The Company’s Resistive RAM (ReRAM) addresses the growing need for higher performance and lower power non-volatile memory (NVM) solutions in a range of new electronic products, such as Internet of Things (IoT) devices, smartphones, robotics, autonomous vehicles, fifth generation (5G) communications and artificial intelligence. Its ReRAM technology is based on fab-friendly materials and can be easily integrated with existing flows and processes. The firm is creating ReRAM IP that customers can embed in their system-on-chip (SoC) designs. The company is also developing discrete (stand-alone) memory technology, targeting storage class memory, persistent memory and NOR flash replacement.

πŸ™Œ Performance (5Yr p.a)

83.85%

πŸ“Š Share price

$2.07 AUD

πŸ€– TECHNOLOGY

VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.

πŸ™Œ Performance (5Yr p.a)

3.71%

πŸ“Š Share price

$66.50 AUD

🌏 GLOBAL

⛳️ DIVERSIFIED

Want more shares? Try these...

πŸ“Š Share price

$0.00 AUD

Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. The firm's product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer's disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury.

πŸ™Œ Performance (5Yr p.a)

-16.62%

πŸ“Š Share price

$0.04 AUD

🧬 BIOTECHNOLOGY

Noronex Ltd. engages in exploration of mineral deposits projects in Australia and overseas. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2017-11-15. Its exploration package in Namibia covers 8,700 square kilometers (km2) with 3,500 kilometers (km) of applications in place on the prospective but relatively underexplored Kalahari Copper Belt which runs from central Namibia to northern Botswana. The tenements contain 300 km of strike length targeting the key NPF-D’Kar formation contact point where copper deposits occur in the Kalahari Copper Belt. Its Namibian exploration program is on the Witvlei, Snowball and Humpback Projects. The Snowball project lies to the east along a strike from Witvlei into the mineralized NPF-Eskadron Formation. The Snowball project is 30 km to the north-east of its existing Witvlei Copper Project. The company also has an agreement to acquire an 80 % interest in the Uranium Belt Project (EPL 6776), which covers 7,000 hectares and is located over three km north of the Etango project.

πŸ™Œ Performance (5Yr p.a)

-13.33%

πŸ“Š Share price

$0.01 AUD

⛏️ MINING

πŸ“Š Share price

$0.00 AUD
Compare
Add to watchlist